INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 111 filers reported holding INSMED INC in Q1 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,000 | 0.0% | 130 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | -97.0% | 130 | -96.8% | 0.00% | -100.0% |
| Q4 2020 | $134,000 | +3.1% | 4,030 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $130,000 | +51.2% | 4,030 | +29.6% | 0.01% | +40.0% |
| Q2 2020 | $86,000 | +72.0% | 3,110 | -1.3% | 0.01% | +66.7% |
| Q1 2020 | $50,000 | -33.3% | 3,150 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $75,000 | +33.9% | 3,150 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $56,000 | -5.1% | 3,150 | +36.4% | 0.00% | 0.0% |
| Q2 2019 | $59,000 | -11.9% | 2,310 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $67,000 | -50.4% | 2,310 | -65.4% | 0.00% | -50.0% |
| Q3 2018 | $135,000 | -23.7% | 6,670 | -10.8% | 0.00% | -20.0% |
| Q2 2018 | $177,000 | +6.6% | 7,480 | +1.2% | 0.01% | 0.0% |
| Q1 2018 | $166,000 | -84.8% | 7,390 | -86.5% | 0.01% | -87.5% |
| Q2 2014 | $1,091,000 | +0.2% | 54,580 | -4.6% | 0.04% | -4.8% |
| Q1 2014 | $1,089,000 | – | 57,210 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |